January 13, 2022   |   Growth Equity News Healthcare

PetDx and IDEXX expand access to Onco/K9, the cancer liquid biopsy test for Dogs

Declaration is proud to support PetDx as it successfully advances the adoption of its non-invasive canine oncology test, most recently in partnership with IDEXX Reference Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation.